{
  "ticker": "JNJ",
  "target_date": "2025-10-30",
  "actual_date": "2025-10-30",
  "collected_at": "2025-12-08T12:28:17.269639",
  "price": {
    "open": 185.9,
    "high": 188.19,
    "low": 185.73,
    "close": 187.8572540283203,
    "volume": 7072500,
    "change_1d_pct": 1.31,
    "change_7d_pct": -1.47,
    "change_30d_pct": 8.55
  },
  "technicals": {
    "rsi_14": 44.35,
    "sma_20": 189.28,
    "sma_50": 181.93,
    "macd": 1.789,
    "macd_signal": 2.788,
    "macd_histogram": -0.999,
    "bb_upper": 193.25,
    "bb_lower": 185.32,
    "price_vs_sma20_pct": -0.75,
    "price_vs_sma50_pct": 3.26,
    "volume_ratio": 0.85
  },
  "fundamentals": {
    "market_cap": 487737720832,
    "pe_ratio": 19.54054,
    "forward_pe": 19.098112,
    "price_to_book": 6.144414,
    "price_to_sales": 5.292925,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.58,
    "pct_from_52w_low": 43.9
  },
  "macro": {
    "spy": {
      "price": 679.83,
      "change_1d_pct": -1.1,
      "change_7d_pct": 1.8
    },
    "vix": {
      "level": 16.91,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.09
    },
    "dollar_index": {
      "level": 99.53
    },
    "gold": {
      "price": 4001.3
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Top Analyst Reports for Broadcom, Johnson & Johnson and Palantir",
      "source": "Yahoo",
      "datetime": 1761858000,
      "summary": "Broadcom's AI surge, J&J's resilient growth, and Palantir's defense-driven momentum headline today's top analyst reports.",
      "url": "https://finnhub.io/api/news?id=3d6c8b66b0640861d0715678cf516dc59ba0eaca55952baf49d5e80f42262d10"
    },
    {
      "headline": "Bladder Cancer Market - Global and Regional Analysis and Forecast (2025-2035) Featuring Merck & Co., Bristol Myers Squibb, Astellas Pharma, AstraZeneca, and Johnson & Johnson",
      "source": "Yahoo",
      "datetime": 1761844560,
      "summary": "Dublin, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The \"Bladder Cancer Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035\" has been added to ResearchAndMarkets.com's offering.The market's growth is primarily driven by the rising incidence of bladder cancer, advancements in diagnostic t",
      "url": "https://finnhub.io/api/news?id=9a0326b70bd21d4034bf6fd8947f86a65c4eb02d4b5a41850de931e9a4df3c99"
    },
    {
      "headline": "Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock",
      "source": "Yahoo",
      "datetime": 1761831602,
      "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
      "url": "https://finnhub.io/api/news?id=b98e313481237248ba475f9a12a41223dff0780d7fab110209859337fe084791"
    },
    {
      "headline": "Bristol Myers Squibb Stock Rises After Solid Earnings. But These Problems Remain.",
      "source": "Yahoo",
      "datetime": 1761823920,
      "summary": "Bristol Myers Squibb  hiked its full-year guidance on the back of a strong third quarter underlined by demand for drugs within its growth portfolio.  The pharmaceutical giant raised its full-year revenue guidance to a range of $47.5 billion to $48 billion from a previous forecast of $46.5 billion to",
      "url": "https://finnhub.io/api/news?id=110f0830813ac85201f26d77bc43a593a1a6c7ab03256a56326c24a669b16259"
    },
    {
      "headline": "Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2025 Financial Results",
      "source": "Yahoo",
      "datetime": 1761820200,
      "summary": "RAHWAY, N.J., October 30, 2025--Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2025 Financial Results",
      "url": "https://finnhub.io/api/news?id=35d1a550acc03b16b9fabeff7e6485c646a32923ef0a177b185a476b0e35f10f"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "10-Q",
      "date": "2025-10-22",
      "description": "jnj-20250928.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/jnj-20250928.htm"
    },
    {
      "form": "4",
      "date": "2025-10-20",
      "description": "xslF345X05/wk-form4_1761002033.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000204/xslF345X05/wk-form4_1761002033.xml"
    },
    {
      "form": "8-K",
      "date": "2025-10-14",
      "description": "jnj-20251014.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000201/jnj-20251014.htm"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627547.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000196/xslF345X05/wk-form4_1757627547.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627315.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000194/xslF345X05/wk-form4_1757627315.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}